Clinical and Translational Radiation Oncology
Publisher: Elsevier · ISSN 2405-6308 · 92 articles
- Feasibility of dose accumulation for assessing treatment-related side effects in MR-guided abdominal SABR: A single-institution study
- Outcomes of elderly patients treated with chemoradiotherapy for anal squamous cell carcinoma: a multicenter study of the German cancer consortium - radiation oncology group (DKTK-ROG)
- Early adverse events and patient-reported outcomes after salvage radiotherapy following prostatectomy according to fractionation schedule: Interim analysis of the phase III URONCOR 06–24 trial
- Adjuvant immune checkpoint inhibition for esophageal squamous cell carcinoma with residual disease after neoadjuvant therapy: A systematic review and meta-analysis
- Quantitative Cosmesis evaluation and clinical outcomes following HDR brachytherapy for head and neck nonmelanoma skin cancers
- A systematic review of heterogeneity in clinical trial design for anal cancer radiotherapy-immunotherapy combinations
- Total neoadjuvant therapy for rectal cancer: where are we now, where do we go?
- Radiotherapy for postoperative groin lymphatic fistulas: A systematic review of clinical outcomes and treatment planning
- Deep-learning–assisted brain contouring and serial neurocognitive monitoring in head and neck cancer survivorship: a prospective study
- Integrating submandibular gland transfer with proton therapy to preserve salivary function
- European lung cancer congress 2026 – the thoracic radiation oncologist's view.
- Patient-reported outcomes in studies of STereotactic arrhythmia Radioablation for ventricular tachycardia (PRO-STAR) – A scoping review on behalf of the STOPSTORM.Eu consortium
- Comment on “Is rectal preparation necessary in contemporary image-guided prostate radiotherapy?”
- ESTRO guideline on radiotherapy in Merkel cell carcinoma
- Systematic review of short course radiation therapy with dose escalation for rectal cancer
- Quantitative dosimetric analysis of patterns of local recurrence after IMRT for primary undifferentiated pleomorphic sarcoma of the extremity
- Reply to Miszczyk et al. ‘focal therapy for prostate Cancer: is the “best available evidence” good enough?
- Prostate and pelvic SABR with or without a focal boost: results from a multicenter phase II prospective clinical trial
- Acute breast edema during 5-fraction ultra-hypofractionated radiotherapy after breast-conserving surgery: A cone-beam CT based evaluation
- Discordance between clinician- and patient-reported outcomes during radiotherapy for brain metastases: the prospective NeuroPRO study
- Validation and refinement of the N classification for nasopharyngeal carcinoma based on the 9th version AJCC/UICC TNM staging system in non-endemic regions of China: a multicenter cohort study
- PACTUS: A two-week radiotherapy regimen for patients with anal squamous cell carcinoma unsuitable for standard chemoradiotherapy—a retrospective single-centre experience
- Hypofractionated and stereotactic body proton radiotherapy for a high-risk lung cancer cohort: A multi-institutional experience from the proton collaborative group prospective registry
- Patterns and predictors of intrafractional tumor displacement assessed by pre- and post-treatment CBCT during end-exhalation breath-hold lung stereotactic body radiation therapy
- Daily adaptive 1.5 T MR-Linac image-guided re-irradiation for prostate cancer: an international retrospective experience
- Friday again: Timing and referral patterns of acute radiotherapy in a tertiary supraregional care network
- “Clinical outcomes of definitive interstitial/hybrid high-dose-rate and pulsed-dose-rate interventional radiotherapy (brachytherapy) for non-melanoma skin cancer: A single-center retrospective analysis”
- Rapid response MR-guided radiotherapy for single fraction metastatic cord compression (MSCC) treatment (RESONATE): A study protocol
- Impact of residual suspicious lymph nodes after axillary lymph node dissection and radiotherapy in breast cancer patients
- Ablative magnetic resonance–guided radiation for gastrointestinal neuroendocrine tumors: assessing local control and toxicity